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Abstract: Background: Falls are common among elderly adults, and are predictors of hospitaliza-
tion, institutionalization and mortality.  
Objective: The objective of the present study was to examine the relationship between blood-based 
markers of inflammation and fall events in a sample of elderly Hispanic adults. 
Method: Data were collected from 190 participants enrolled in the Panama Aging Research Initia-
tive study who completed baseline clinical and cognitive assessments. A non-fasting blood sample 
was obtained. Self-reported falls were classified as no falls, single falls or recurrent (two or more) 
falls reported in the 12 months prior to baseline evaluations. Serum levels of C Reactive Protein 
(CRP), T-lymphocyte secreting protein (I-309), interleukin 10 (IL-10), interleukin 6 (IL-6) and in-
terleukin 7 (IL-7) were measured. Global cognition was assessed with the Mini Mental State Ex-
amination and depressive symptoms were assessed with the Geriatric Depression Scale (GDS-30). 
Multinomial logistic regression was used to assess the link between inflammation and fall events.  
Results: Depressive symptoms, limitations in Instrumental Activities of Daily Living (IADL), IL-7 
and I-309 were significantly related to fall events. Elevated levels of IL-7 increased the likelihood 
of single and recurrent falls, while increased levels of I-309 were associated only with recurrent 
falls. Greater IADL limitations and depressive symptoms were associated with an increased likeli-
hood of recurrent falls.  
Conclusion: There is a lack of research investigating the relationship between inflammatory bio-
markers and fall events. These results provide evidence of risk factors for falls in Hispanic older 
adults, and could serve to guide public health professionals to establish clinical guidelines to reduce 
fall risks.  
Keywords: Aging, disability, inflammation, depression, Hispanics, Latin America. 
1. INTRODUCTION 
 Falls have a significant impact on health outcomes in the 
elderly [1]. As the number of falls increases elderly adults 
experience a greater risk of hospitalization and mortality. 
Fall-related injuries can result in physical limitations that 
impact the capacity to perform daily activities independently, 
place a significant burden on caregivers, and are a leading 
cause of institutionalization [2]. Moreover, depressive symp-
toms, which are common among older adults, have been 
shown also to be associated with falls [3, 4]. Fall events are 
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linked to multiple causes, and so the identification and as-
sessment of factors related to falls could aid in fall preven-
tion [5-7]. 
 Identification of biomarkers that are related to fall events 
may provide clues into the pathophysiological mechanisms 
related to falls, which in turn, could lead to novel approaches 
for identifying individuals at risk for progressing to worse 
health states. Although several studies have investigated the 
relationship between inflammatory biomarkers and other 
age-related conditions, such as cognitive impairment and 
depression [8], few studies have focused on the relationship 
between inflammatory markers and falls. Because the im-
mune system undergoes extensive remodeling over the 
course of aging and has a major impact on an individual’s 
health and survival, an examination of the link between in-
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flammation and falls could shed light on intervention strate-
gies aimed at preventing falls. 
 Most studies that have examined risk factors associated 
with falls have been conducted in non-Hispanic white popu-
lations, while few have included diverse racial/ethnic minori-
ties [9-11]. Moreover, a significant proportion of the world’s 
aging population lives in developing countries, which will 
carry a greater share of the burden associated with falls [12]. 
Despite this, evidence of falls in older adults in developing 
countries is scarce. The objective of this study was to iden-
tify the factors associated with falling in elderly Hispanic 
adults in Panama. Clinical characteristics, cognitive function, 
and depressive symptoms, in addition to five inflammatory 
markers, were assessed in elderly adults who reported no 
falls, one fall or recurrent falls in order to establish clinical 
signs of fall risk. Factors that increase with age and may im-
pact this relationship include chronic illness comorbidity, 
functional limitations, a history of falls, cognitive impair-
ments, depression and physical inactivity [1, 13, 14]. Con-
sidering that the aged population is increasing in Panama, as 
in most developing countries, an increased incidence of 
chronic medical conditions and other age-related disorders is 
expected, and thus research to identify the correlates of fall 
events is timely. 
2. MATERIALS AND METHODS 
2.1 Participants 
 Data from this study came from the Panama Aging Re-
search Initiative (PARI) study, an ongoing study of Panama-
nian aging. The study protocol has been described in detail in 
previous publications [15, 16]. PARI participants were re-
cruited from the outpatient geriatric services of the largest 
public hospital of the Social Security (CSS) located in Pan-
ama, the capital city of Panama. Inclusion criteria were being 
at least 65 years of age, willing to participate in baseline and 
three follow-up interviews over the course of 12-18 months, 
and provision of informed consent. Exclusion criteria in-
cluded any physical or medical condition that required cur-
rent hospitalization or institutionalization or participation in 
an ongoing clinical study at the time of enrollment. The 
study protocol was approved by the National Bioethics 
Committee of the Instituto Conmemorativo Gorgas de Estu-
dios de la Salud and the Institutional Bioethics Committee of 
the CSS. Participants provided written informed consent in 
accordance with the principles of the Declaration of Helsinki 
(1964).  
 The present report constitutes an analysis of the data 
from 190 participants who had complete evaluations during 
the baseline interview and assessment of cognitive function 
and depressive symptoms. At baseline, each participant un-
derwent a physical exam and clinical interview, and provided 
information of demographic factors, medical conditions, fall 
events and functional status. A non-fasting blood sample was 
obtained. Approximately four months later (M=4.5 months, 
SD=1.9) participants underwent cognitive testing and as-
sessments of depressive symptoms. Interviewers included 
physicians, medical students and graduate students. The in-
terviews were conducted in Spanish. Assisted interviews 
(with a relative, informant or caregiver) were carried out in 
12% of cases. 
2.2. Variables and Measurement 
 Participants were asked questions regarding fall events 
(outcome variable) over the 12 months preceding the base-
line interview. We examined the relationship between clini-
cal characteristics and inflammatory biomarkers and the out-
come variable, the likelihood (odds ratio) of having experi-
enced a single fall or recurrent falls (two or more) relative to 
experiencing no falls. Performance in activities of daily liv-
ing was evaluated through self-report as reported previously 
[17]. Subjects were asked to indicate whether they had any 
limitations performing the following seven Basic Activities 
of Daily Living (BADL): transferring, bathing, dressing, 
grooming, toileting, feeding, and urinary continence. Limita-
tions in seven Instrumental Activities of Daily Living 
(IADL) were evaluated: leaving the home independently, 
preparing a meal, using a telephone, grocery shopping, per-
forming basic house chores, and managing finances and 
medications. BADL and IADL items were dichotomized as 
none or at least one. Seven chronic conditions were recorded 
through self-report: hypertension, coronary heart disease, 
diabetes, stroke, cancer, chronic lung disease, and arthritis. 
The number of chronic diseases was coded as a categorical 
disease indicator of whether a participant reported none or 
one, two, or three or more conditions (the smallest two cate-
gories were grouped due to small numbers). The 30-item 
Spanish version of the Mini-Mental State Examination 
(MMSE) was used as a measure of global cognition [18], and 
scores were adjusted for age and level of education [19]. For 
regression analyses two MMSE categories were defined: 
cognitively impaired (< 24) and unimpaired (≥ 24). Depres-
sive symptoms were assessed with the Spanish version of the 
30-item Geriatric Depression Scale (GDS-30) [20, 21]. The 
instrument consists of 30 yes/no items used to identify de-
pression in the elderly, and was applied by the investigator 
reading the items out loud and registering the participant’s 
responses. For regression analyses participants were classi-
fied into one of two categories according to GDS scores. 
Higher scores indicate a greater possibility of depression. 
The standard cut-off score of ≥ 11 depressive symptoms was 
applied to classify depressed individuals [20]. Lastly, par-
ticipants were asked whether they engaged regularly in 
physical activity (moderate to intense activity once a week or 
more), and responses were categorized as yes or no. 
2.3. Biomarkers and Assays 
 Five markers of inflammation were assayed: C-reactive 
protein (CRP), T-lymphocyte secreting protein (I-309), inter-
leukin-6 (IL-6), interleukin-7 (IL-6), and interleukin-10 (IL-
10). Biomarker assays have been described in previous pub-
lications [16, 22, 23]. Briefly, non-fasting morning samples 
were collected with 10 ml serum-separating vacutainer tubes 
and allowed to clot at room temperature before being centri-
fuged at 1300 x g for 10 min, aliquoted (1 ml) into polypro-
pylene cryovial tubes and stored at -80°C. Assays were con-
ducted in duplicate via a multi-plex biomarker assay plat-
form using electrochemiluminescence (ECL) on the Quick-
Plex SQ120 Imager from Meso Scale Discovery (MSD; 
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mesoscale.com) per our previously published protocols [22, 
24]. The MSD platform has been used extensively to assay 
biomarkers associated with a range of human diseases and 
with greater sensitivity than conventional ELISAs. For each 
analyte, values that exceeded the limit of detection in > 75% 
of all the samples for each respective analyte were included 
in the analyses. These criteria were fulfilled by all analytes in 
the present study. We recently published ranges and CVs for 
> 1,000 subjects on these assays [22]. In cases where there 
were values below the limit of detection, we used imputation 
to assign a value that was 1% below the lowest detectable 
value for that analyte (< 1% of cases). 
2.4. Statistical Analysis 
 We first examined relationships between self-reported 
falls (no falls, single fall, or recurrent falls) and demographic 
and clinical characteristics using descriptive statistics. We 
then examined the independent relationships between demo-
graphic and clinical characteristics and falls in an age-, sex- 
and education-adjusted multinomial logistic regression 
analysis. This strategy examined the association between 
clinical and functional variables and single and/or recurrent 
falls, compared to the absence of falls. Age, sex and educa-
tion were included as covariates based on evidence of their 
influence on the relationship between predictors and falls 
[11, 25, 26]. Odds Ratios (OR) and 95% confidence intervals 
(CIs) are reported. All analyses were conducted using SPSS 
21.0. 
3. RESULTS 
 Demographic characteristics of the sample are provided 
in Table 1. Thirty-seven percent (n= 71) of participants re-
ported at least one fall in the twelve months prior to baseline 
assessment. Participant ages ranged from 65 to 102 years 
with a mean age of 78.0 (SD= 7.7). Sixty-five percent of 
participants were female (n= 123) and approximately half of 
the sample (49.5%) completed six years of education (pri-
mary) or less. Sixteen percent of the sample (n= 17) ex-
ceeded the cut-off score of ≥ 11 depressive symptoms and 
were classified as depressed. 
 In sex, age and education-adjusted multinomial logistic 
regression analyses, there were significant associations be-
Table 1. Characteristics of participants who reported no falls, a single fall or recurrent falls. 
No Falls (n= 119) Single Fall (n= 29) Recurrent Falls (n= 42) 
Characteristic 
Mean/% (SD/n) Mean/% (SD/n) Mean/% (SD/n) 
p* 
Age, years 77.9 (7.8) 77.7 (6.8) 78.7 (8.2) NS 
Sex, female 63.9% (76) 65.5% (19) 66.7% (28) NS 
Education, years 8.3 (3.8) 8.5 (4.1) 7.0 (3.7) NS 
Marital Status, not married or partnered 54.6% (65) 51.7% (15) 59.5% (25) NS 
BADL 0.31 (0.08) 0.55 (0.15) 0.50 (0.06) NS 
IADL 1.01 (0.14) 1.76 (0.31)a 1.50 (0.22)a 0.027 
Comorbidity  -  -  - 0.002 
0-1 Conditions 28.6% (34) 20.7% (6) 16.7% (7)  - 
2 Conditions 41.2% (49) 20.7% (6) 21.4% (9)  - 
3+ Conditions 30.3% (36) 58.6% (17) 61.9% (26)  - 
Physical activity, not active 61.3% (73) 86.2% (25) 66.7% (28) 0.040 
Global cognition (MMSE) 25.6 (5.2) 23.6 (4.5) 25.3 (4.5) NS 
Depressive symptoms (GDS-30) 7.1 (0.5) 8.7 (1.3)a 8.7 (0.9)a 0.041 
Biomarkers  -  -  - -  
CRP (ng/ml) 3.34 (0.83) 2.68 (0.56) 5.69 (1.93) NS 
I309 (pg/ml) 3.71 (0.56) 5.10 (0.49) 6.34 (0.60) 0.023 
IL-10 (pg/ml) 1.96 (0.45) 1.15 (0.12) 3.50 (1.62) NS 
IL-6 (pg/ml) 6.22 (2.57) 3.90 (1.44) 4.33 (0.75) NS 
IL-7 (pg/ml) 10.30 (0.60) 13.37 (2.00)a 12.28 (0.86)a 0.037 
Data are means (standard deviation) for continuous variables or percentage (number) for categorical variables. *Continuous variables were analyzed with one-way analysis of vari-
ance followed by Tukey’s post hoc test and categorical variables with chi-square test. aSignificantly different from individuals who reported no falls. SD = Standard Deviation; NS = 
Not Statistically significant (p>0.05); BADL = Basic Activities of Daily Living; IADL = Instrumental Activities of Daily Living; MMSE = Mini-Mental State Exam; GDS-30 = 
Geriatric Depression Scale (30-item); CRP = C Reactive Protein; I309 = T lymphocyte secreted protein; IL-10 = Interleukin 10; IL-6 = Interleukin 6; IL-7 = Interleukin 7. 
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tween IADL limitations, depressive symptoms, and inflam-
matory biomarkers with fall events (Table 2). Participants 
with increased levels of IL-7 were more likely to have re-
ported single or multiple falls than participants who reported 
no falls. Likewise, those with increased I-309 levels were 
more likely to have suffered recurrent falls compared to 
those who reported no falls. In addition, having at least one 
IADL limitation and a greater number of depressive symp-
toms was associated with a greater likelihood of reporting 
recurrent falls. Chronic illness comorbidity, cognitive im-
pairment, lack of physical activity and CRP, IL-10 and Il-6 
levels were not significantly associated with self-reported 
falls. 
4. DISCUSSION 
 Falls are one of the most common problems among older 
individuals threatening their independence and increasing 
morbidity, mortality, hospitalization and institutionalization. 
In the United States, the Centers for Disease Control and 
Prevention (CDC) reports that approximately 25% of older 
adults fall annually [27].  Studies have shown that falls are 
associated with various factors including muscle weakness, a 
history of falls, depressive symptoms and impairments in 
cognition, activities of daily living and balance, among oth-
ers [1].  Many potential biomarkers are being tested for their 
association with age-related disease and prospective mortal-
ity. Thus, the aim of the present study was to examine the 
relationship between self-reported falls and various clinical 
factors and inflammatory biomarkers that have been associ-
ated with aging-related conditions. In the present study, we 
report that depressive symptoms and limitations in instru-
mental activities of daily living, as well as two inflammatory 
biomarkers, IL-7 and I-309, were associated with falls.  
 Among the variables most strongly associated with recur-
rent falls were limitations in IADL and increased depressive 
symptoms. Several studies have shown that falls and fall 
related injuries are associated with functional decline [28] 
and in many cases are independent predictors of functional 
decline in community-dwelling older adults [2]. One study 
found that in younger groups of healthier older adults, those 
who fall frequently or report injury are at highest risk for 
functional dependence in activities of daily living [29]. 
Likewise, in various cross-sectional and longitudinal studies 
depression has been shown to be a potential risk factor for 
falls [25, 30, 31]. Our results indicate a strong likelihood of 
limitations in IADL and depression in recurrent fallers. Par-
ticipants with limitations in at least one IADL who also re-
ported depressive symptomatology were four and two times 
as likely, respectively, to report multiple falls than no falls, 
suggesting that dependent and depressed individuals are at 
the highest risk for frequent falls. 
 There is scarce data available regarding the relationship 
between inflammatory biomarkers and falls. One recent 
study showed that increased 25- hydroxyvitamin D (S-
Table 2. Sex-, age- and education-adjusted multinomial logistic regression analysis examining the relationship between clinical 
characteristics and inflammatory biomarkers and the likelihood of self-reported falls. 
Characteristic Single Fall OR [95% CI] (Ref: No Falls) Multiple Falls OR [95% CI] (Ref: No Falls)  
Not married/partnered 0.65 [0.12-3.61] 0.48 [0.12-1.90] 
BADL (at least one limitation) 0.19 [0.02-1.74] 0.64 [0.14-2.85] 
IADL (at least one limitation) 1.45 [0.19-11.07] 4.28* [1.03-17.73] 
Comorbidity -  -  
0-1 Conditions - - 
2 Conditions 1.91 [0.23-15.48] 0.40 [0.07-2.41] 
3+ Conditions 0.93 [0.11-8.29] 1.08 [0.22-5.21] 
Physical activity, not active 2.30 [0.68-7.70] 0.85 [0.36-2.03] 
Global cognition (MMSE) 1.92 [0.72-5.11] 1.11 [0.48-2.57] 
Depressive symptoms (GDS-30) 0.82 [0.06-11.41] 2.30* [1.48-11.01] 
Biomarkers -  -  
CRP (ng/ml) 1.00 [0.89-1.10] 1.00 [0.65-1.17] 
I309 (pg/ml) 1.13 [0.98-1.32] 1.76* [1.10-2.36] 
IL-10 (pg/ml) 0.60 [0.18-2.01] 1.00 [0.89-1.12] 
IL-6 (pg/ml) 0.98 [0.91-1.06] 1.00 [0.95-1.05] 
IL-7 (pg/ml) 1.20** [1.04-1.37] 1.14* [1.01-1.29] 
Note: This analysis controls for age, sex and education. OR = odds ratio; BADL = Basic Activities of Daily Living; IADL = Instrumental Activities of Daily Living; MMSE = Mini-
Mental State Exam; GDS-30 = Geriatric Depression Scale (30-item); CRP = C Reactive Protein; I309 = T Lymphocyte-Secreted Protein; IL-10 = Interleukin 10; IL-6 = Interleukin 
6; IL-7 = Interleukin 7. Significance levels are indicated at *p < .05; **p < .01. 
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25(OH)D), a marker of skeletal devepment, was associated 
with fewer falls in a cohort of Finnish home-dwelling 
women [32]. In other studies, a meta-analysis of factors 
associated with frailty and pre-frailty, which pose the threat 
of an increased risk of age-related complications including 
fall incidents, showed that frailty status was associated  
with significantly higher levels of serum inflammatory 
biomarkers such as CRP and IL-6 [33]. Similar results were 
found for plasma concentrations of other inflammatory gly-
coproteins (transferrin, fibrinogen, and IL-6) and frailty 
[34]. Together, studies examining frailty suggest that in-
flammatory proteins may be helpful in the assessment  
of physical decline as a complement to the clinical evalua-
tion and assessment. Moreover, falls and frailty, although 
defined differently, share many characteristics, and thus 
both may provide some insight into age-related disease 
processes.  
 In the present study, analysis of the five biomarkers 
assessed revealed that higher levels of IL-7 and I-309 were 
significantly associated with a greater likelihood of falls. 
Previous work has shown that IL-7 and its receptor, IL-7R, 
are implicated in the differentiation, proliferation, and sur-
vival of immune cells, and recent studies have supported 
the IL-7 pathway as a biomarker of successful aging [35], 
although results have not been consistent. In general, stud-
ies support a critical role for the IL-7 pathway in the ho-
meostasis of the immune system and in the maintenance of 
healthspan during aging. In one study, longevity was asso-
ciated with low levels of IL-7R, [35]  which limits the 
number of cells capable of responding to IL-7 [36]  and 
also reduces levels of serum IL-7 [37]. However, the rela-
tionship between levels of IL-7R gene expression and ten-
year mortality was found to be age dependent; in nonage-
narians higher levels of IL-7R were associated with longer 
lifespan [35]. On the other hand, individuals suffering from 
autoimmune disease express increased levels of IL-7R 
complex genes [38, 39]. In sum, the IL-7 pathway appears 
to be implicated in the rate of aging but in an age- and 
health-dependent manner. Here we show that fall events are 
associated with an increase in this serum marker. Further 
work is needed to clarify the mechanisms that link IL-7 to 
fall events and to healthspan in general. 
 To our knowledge, no studies have linked I-309 to fall 
events in the elderly, although several studies have linked I-
309 with Alzheimer’s Disease (AD) [16, 24, 40, 41], the 
most common form of dementia in the elderly. I-309 is a 
small glycoprotein secreted by activated T cells that belongs 
to a family of inflammatory cytokines known as chemokines. 
In recent studies from our laboratory in which we established 
blood-based biomarker profiles of AD and Mild Cognitive 
Impairment (MCI) compared with subjects with normal cog-
nition, I-309 was the number one marker in the risk score for 
both AD and MCI [16], and was found to be significantly 
elevated in both MCI and AD subjects relative to controls. 
Moreover, I-309 was among the top 10 markers that over-
lapped with those from our cross-validated 21 serum-based 
biomarker panel for AD [24]. Levels of I-309 in cerebrospi-
nal fluid, assessed post-mortem, were also found to be inde-
pendently associated with the severity of cognitive impair-
ment in AD but not with other neurodegenerative disorders  
 
[41]. Because I-309 is associated with the inflammatory re-
sponse, these findings suggest that falls, like AD, are associ-
ated with immune system dysfunction.  
 This study has several limitations, the most important 
being the cross-sectional design of the study. Ongoing as-
sessments are being conducted every 18-24 months and the 
link between baseline measures and risk of future fall 
events is now being investigated. Another limitation is that 
the findings cannot be generalized to elderly adults who are 
institutionalized or hospitalized. More extensive studies, 
preferably randomized controlled trials with larger sample 
sizes, will shed light on risk factors associated with fall 
events. 
CONCLUSION 
 Biomarkers can improve our understanding of and risk 
for age-associated conditions, changes in health status, mor-
bidity, and mortality. The present study has shown the rela-
tionship between inflammatory biomarkers to the incidence 
of falls in elderly adults. The association of two inflamma-
tory markers, IL-7 and I-309, with single and/or recurrent 
falls, with depressive symptoms, and with limitations in the 
capacity to carry out everyday activities stand out as strong 
predictors of recurrent falls in particular. These findings sup-
port a role of inflammatory biomarkers in the likelihood of 
falls, and emphasize that co-existing medical conditions 
should be included in assessments looking for potential risk 
factors. 
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